Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Treatment Clinical Trials for Soft Tissue Sarcoma

Review the soft tissue sarcoma treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-100 of 122

Abemaciclib for the Treatment of Patients with HIV-Associated and HIV-Negative Kaposi Sarcoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Retifanlimab with or without Gemcitabine and Docetaxel in Patients with Advanced, Unresectable or Metastatic Soft Tissue Sarcoma
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients with Soft Tissue Sarcoma, Bone Sarcoma, or Colorectal Cancer Metastatic to the Lungs
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Modified Donor Peripheral Blood Stem Cells in Combination with Zoledronic Acid for the Treatment of Pediatric, Adolescent, and Young Adult Patients with Relapsed or Refractory Solid Tumors
Status: Active
Location: University of Florida Health Science Center - Gainesville, Gainesville, Florida
A Study of Repotrectinib in Combination with Chemotherapy in Children and Young Adults with Solid Tumor Cancer
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Status: Active
Location: 2 locations
Tivozanib and Atezolizumab for the Treatment of Advanced, Unresectable, or Metastatic Immunologically Cold Tumor Types
Status: Active
Location: University of Florida Health Science Center - Gainesville, Gainesville, Florida
Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Fampridine in Combination with Imatinib Mesylate before Surgery for the Treatment of KIT Exon 11 Mutant Gastrointestinal Stromal Tumor (GIST)
Status: Active
Location: UC San Diego Moores Cancer Center, La Jolla, California
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
ACTengine® IMA203 Combined With mRNA-4203
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Gemcitabine and Nab-Sirolimus for the Treatment of Patients with Advanced Leiomyosarcomas or Soft-Tissue Sarcomas with TSC2 or TSC1 Loss-of-Function Mutations or Deletions
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Genetically Engineered Cells (NY-ESO-1 TCR/IL-15 NK cells) for the Treatment of Patients with Relapsed or Refractory Synovial Sarcoma, Myxoid Liposarcoma, or Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (AttIL12-TIL) for the Treatment of Locally Advanced or Metastatic Soft Tissue and Bone Sarcoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Study of NB003 in Patients with Advanced Malignancies
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
A Study of EGFR806 CAR T-Cell Immunotherapy for Treating Children and Young Adults with Recurrent/Refractory Solid Tumors
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Palbociclib with Pembrolizumab for the Treatment of Patients with Locally Advanced, Metastatic or Unresectable Sarcomas
Status: Active
Location: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
Tumor Infiltrating Lymphocytes for the Treatment of Children with High Risk Solid Tumors
Status: Active
Location: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Papaverine Hydrochloride and Stereotactic Body Radiation Therapy in Treating Patients with Non-small Cell Lung Cancer or Lung Metastases
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland